-
First Vioxx Lawsuit Trial Starts in Brazoria County, Texas: Ernst vs. Merck
Vioxx Trial in Texas Expected to Be at Least Five Weeks Before Jury Verdict Merck & Co. is currently engaged in the first trial of a lawsuit involving Vioxx, and there are thousands of…
-
Duragesic Pain Patch: Johnson & Johnson Adds Warning to Label and Sends “Dear Doctor” Letter
FDA Follows With Public Health Advisory on Duragesic and Other Fentanyl Patches On July 8, 2005 Johnson & Johnson Inc. added warnings about possible misuse and abuse to its Duragesic pain patch package insert…
-
Scios Sends Second “Dear Doctor” Letter On Heart Drug Natrecor
Cardiologist Eric Topol Calls For Limited Use of Johnson & Johnson Drug Natrecor On July 13, 2005 the Scios division of Johnson & Johnson sent a second "Dear Doctor" letter about Natrecor, a heart-failure…
-
Crestor: Full-court Press on CBS News Reporter Sharyl Attkisson
Numerous Doctors Lined-Up to Sing Praises of Crestor for CBS News Report There is an insightful article published in the July/August 2005 edition of the Columbia Journalism Review (CJR), Bitter Pill: How the press…
-
Health Canada Advisory About Statins and Rhabdomyolysis Side Effect
July 2005 Statin Advisory Provides Patients With Important Safety Information On July 12, 2005 Health Canada issued an advisory about rhabdomyolysis being a serious side effect of all cholesterol-lowering drugs known as statins. Specifically,…
-
Recent Study Shows How Vioxx, Bextra, and Celebrex Can Damage Heart
A Theory of Why COX-2 Inhibitors Affect the Heart and Raise Heart Attack Risk In May 2005 it was reported that medical researchers affiliated with the University of Pennsylvania School of Medicine have…
